[Federal Register: August 5, 2003 (Volume 68, Number 150)]
[Notices]               
[Page 46199]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05au03-67]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 1991D-0425]

 
Guideline for the Clinical Evaluation of Analgesic Drugs; 
Withdrawal of Guidance

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal of a guidance entitled ``Guideline for the Clinical 
Evaluation of Analgesic Drugs,'' which was issued on December 1, 1992. 
The guidance is outdated and no longer reflects FDA's current thinking 
on development of analgesic drugs. FDA is revising the guidance and 
will issue a draft for public comment in the future.

DATES: Comments on agency guidances are welcome at any time.

FOR FURTHER INFORMATION CONTACT: Barbara J. Gould, Center for Drug 
Evaluation and Research (HFD-550), Food and Drug Administration, 5600 
Rockville Pike, Rockville, MD 20850, 301-827-2504.

    Dated: July 28, 2003.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 03-19802 Filed 8-4-03; 8:45 am]

BILLING CODE 4160-01-S